Allaxys Communications --- Transponder V --- Allaxys Forum 1

Pages: [1]

Author Topic: WICHTIGE INFORMATIONEN ZU MALARIA  (Read 1322 times)

ama

  • Jr. Member
  • *
  • Posts: 1276
WICHTIGE INFORMATIONEN ZU MALARIA
« on: May 23, 2007, 04:07:26 PM »

Meldung in
http://derStandard.at/Text/Corporate/?ressort=Wissenschaft

[*QUOTE*]
--------------------------------------------------------------------------
23.05.2007 19:08
Kampf gegen Malaria: So simpel, so effektiv
Um alle gefährdeten Kleinkinder und werdenden Mütter in Afrika zu
schützen, bräuchte es etwa 192 Millionen Moskito-Netze
--------------------------------------------------------------------------
[*/QUOTE*]



In dieser Übersichtsseite sind sehr wichtige Links:

http://jama.ama-assn.org/cgi/content/full/297/20/2167

[*QUOTE*]
--------------------------------------------------------------------------
Vol. 297 No. 20, May 23/30, 2007

JAMA

This Week in JAMA
JAMA.2007;297:2167.

MALARIA
A JAMA THEME ISSUE
Edited by Gianna Zuccotti, MD, MPH, and Catherine D.
DeAngelis, MD, MPH

Treatment of Plasmodium vivax Malaria
When Plasmodium falciparum and Plasmodium vivax coexist
and species-specific malaria diagnosis is difficult, treatment
that is efficacious against both species is desirable. Leslie and
colleagues conducted a randomized trial testing the relative
efficacy and safety of 2 antifolate therapies vs chloroquine for
This Article

PDF

Send to a friend

Save in My Folder

Save to citation
manager

Permissions
Citing Articles

Contact me when
this article is cited
Related Content

Similar articles in JAMA

P vivax malaria in Pakistan and Afghanistan. They found that although
chloroquine is the drug of choice, all 3 therapies effectively cleared
parasites by day 14 and were well tolerated.
(SEE ARTICLE)

Combination Antimalarial Therapy in Children
In a randomized trial involving Ugandan children with first-episode
uncomplicated falciparum malaria, Dorsey and colleagues compared the
efficacy and safety of 3 combination regimens and found that
artemether-lumefantrine was associated with the lowest 28-day risk of
parasitological failure.
(SEE ARTICLE)

Hemoglobin Variants and Signs of Severe Malaria
In a case-control study involving children with severe falciparum malaria,
May and colleagues found that the hemoglobin S carrier state was
negatively associated with all major manifestations of severe disease,
whereas the hemoglobin C and  +-thalassemia carrier states were negatively
associated with cerebral malaria and severe anemia, respectively.
(SEE ARTICLE)

Diagnostic Testing and Malaria Treatment
Among patients with fever seen at Zambian health facilities having either
microscopy or malaria rapid diagnostic testing capabilities, Hamer and
colleagues found that only 27.8% of patients had diagnostic testing
performed, and patients with negative test results were often prescribed
antimalarial agents.
(SEE ARTICLE)

Neurological Features of Malaria in Children
Idro and colleagues reviewed patient records for Kenyan children younger
than 14 years who were admitted to the hospital with acute falciparum
malaria and found that almost half had neurological involvement, most
often seizures or impaired consciousness or coma, and with an associated
higher risk of mortality or neurological sequelae.
(SEE ARTICLE)

Insecticide-Treated Nets in Africa
In an analysis of survey data reflecting the availability of
insecticide-treated nets (ITNs) in 43 African countries, Miller and
colleagues estimated that 16.7 million ITNs were available in households
at risk in 2003. They calculate that between 130 million and 264 million
ITNs will be required in 2007 to reach an 80% coverage target for young
children and pregnant women in these countries.
(SEE ARTICLE)
CLINICIAN'S CORNER

Malaria in the United States
Griffith and colleagues report results of a systematic literature review
of diagnostic modalities and available pharmacotherapies to guide the
rapid diagnosis and appropriate treatment of malaria in patients in the
United States.
(SEE ARTICLE)

A Piece of My Mind
"Fighting diseases such as malaria in Africa requires opening the space
for dialogue, not just at the political and governmental levels, but
within communities." From "Don't Sleep With Your Chickens."
(SEE ARTICLE)

Medical News & Perspectives
Malaria researchers are seeking better drugs and ways to control the
parasite's mosquito vectors.
(SEE ARTICLE)

Chemoprophylaxis for Travelers
Controversies and misconceptions reflected in national chemoprophylaxis
guidelines.
(SEE ARTICLE)

Drug Resistance
Make global surveillance to detect artemisin resistance a priority.
(SEE ARTICLE)

Global Malaria Control
Strong leadership, effective management, and sufficient funding could make
global malaria control a reality.
(SEE ARTICLE)

Malaria 2007
The issue editors discuss progress and challenges in malaria control.
(SEE ARTICLE)

LITERATIM
Contagious Narratives
Epidemics revisited for today's readers.
(SEE ARTICLE)
JAMA Patient Page
For your patients: Information about malaria.
(SEE ARTICLE)
HOME | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | CME | CAREERNET |
CONTACT US | HELP CONDITIONS OF USE | PRIVACY POLICY

© 2007 American Medical Association. All Rights Reserved.
--------------------------------------------------------------------------
[*QUOTE*]
.
« Last Edit: May 23, 2007, 04:15:30 PM by ama »
Logged
Kinderklinik Gelsenkirchen verstößt gegen die Leitlinien

Der Skandal in Gelsenkirchen
Hamer-Anhänger in der Kinderklinik
http://www.klinikskandal.com

http://www.reimbibel.de/GBV-Kinderklinik-Gelsenkirchen.htm
http://www.kinderklinik-gelsenkirchen-kritik.de

ama

  • Jr. Member
  • *
  • Posts: 1276
WICHTIGE INFORMATIONEN ZU MALARIA
« Reply #1 on: May 23, 2007, 04:11:42 PM »

Über diesen Abstract kommt man zu dem Volltext:

http://jama.ama-assn.org/cgi/content/short/297/20/2241

[*QUOTE*]
--------------------------------------------------------------------------
Vol. 297 No. 20, May 23/30, 2007
JAMA

Online Features
Review
Estimating the Number of Insecticide-Treated
Nets Required by African Households to Reach
Continent-wide Malaria Coverage Targets


John M. Miller, MPH; Eline L. Korenromp, PhD;
Bernard L. Nahlen, MD; Richard W. Steketee, MD
JAMA.2007;297:2241-2250.
Context African countries are scaling up malaria
interventions, especially insecticide-treated nets (ITNs), for
which ambitious coverage targets have been set.
Objective To estimate how many ITNs are available in
African households that are at risk of malaria and how many
ITNs are needed to reach targets for use by children younger
than 5 years and pregnant women.
Data Sources Primary sources of data were the Multiple
Indicator Cluster Surveys II, the Demographic and Health
Surveys, or other nationally representative or large-scale
household surveys that measured household possession and
use of nets or ITNs among children younger than 5 years.
Data Extraction Data from 42 household surveys between
1999 and 2006 on net and ITN coverage (either household
possession or use) and average numbers of nets and ITNs per
household were compared with populations and households at
risk. Data are included for 43 sub-Saharan African countries.
Data Synthesis For the median survey year 2003, the
population-weighted mean proportion of households
possessing at least 1 ITN was 6.7% (range among countries,
0.1%-71.0%) and was 23.8% (range, 5.0%-91.2%) for any
type of net. Based on an average of 0.13 ITNs per household,
This Article

Full text

PDF

Send to a friend

Save in My Folder

Save to citation
manager

Permissions
Citing Articles

Citing articles on
HighWire

Contact me when
this article is cited
Related Content

Related article

Similar articles in
JAMA
Topic
Collections

World Health

Public Health, Other

Review

Malaria

Alert me on articles
by topic

we estimated that 53.6 million nets, of which 16.7 million were ITNs, were
available in households at risk of malaria. Between 130 million and 264
million ITNs are required in 2007 to reach the 80% coverage target for
about 133 million children younger than 5 years and pregnant women living
in 123 million households in risk areas; the exact number depends on usage
patterns (best estimate, assuming 55% of owned ITNs are used by the target
groups, 192 million ITNs).
Conclusion To achieve the targeted ITN usage rates, numbers of ITNs
available to African households must be dramatically increased.
Author Affiliations: PATH Malaria Control and Evaluation Partnership in
Africa (MACEPA), National Malaria Control Centre, Lusaka, Zambia (Mr
Miller);
Department of Epidemiology, Tulane University School of Public Health and
Tropical Medicine, New Orleans, La (Mr Miller); The Global Fund to Fight
AIDS, Tuberculosis and Malaria, Geneva, Switzerland (Drs Korenromp and
Nahlen);
Erasmus MC, University Medical Centre Rotterdam, Department of Public
Health, Rotterdam, the Netherlands (Dr Korenromp); and PATH MACEPA,
Batiment Avant Centre, Ferney-Voltaire, France (Dr Steketee).
RELATED ARTICLE
This Week in JAMA
JAMA. 2007;297:2167.

FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Malaria 2007--Progressing Research, Persisting Challenges
Zuccotti and DeAngelis
JAMA 2007;297:2285-2286.
FULL TEXT  
HOME | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | CME | CAREERNET | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US

© 2007 American Medical Association. All Rights Reserved.
--------------------------------------------------------------------------
[*/QUOTE*]
.
Logged
Kinderklinik Gelsenkirchen verstößt gegen die Leitlinien

Der Skandal in Gelsenkirchen
Hamer-Anhänger in der Kinderklinik
http://www.klinikskandal.com

http://www.reimbibel.de/GBV-Kinderklinik-Gelsenkirchen.htm
http://www.kinderklinik-gelsenkirchen-kritik.de
Pages: [1]